Juthaporn Cowan
MD, PhD, FRCPC
Associate Scientist, Inflammation and Chronic Disease
Ottawa Hospital Research Institute
Associate Professor, Department of Medicine
Division of Infectious Diseases
Assistant Professor, Department of Biochemistry
Microbiology and Immunology
Contact
(613)737-8899 ext. 79617
Administrative Coordinator: Andrea Angelo aangelo@toh.ca
Bio
Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Associate Professor at The University of Ottawa, Division of Infectious Diseases, Department of Medicine and Department of Biochemistry, Microbiology, and Immunology. She is an Infectious Diseases physician at The Ottawa Hospital.
Dr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She completed Internal Medicine and Adult Infectious Diseases training at the University of Ottawa.
Dr. Cowan is the medical lead for the Ontario Immunoglobulin Treatment Program (ONIT). The ONIT Program is a Ministry of Ontario approved initiative to improve the healthcare of patients with immunodeficiencies requiring immunoglobulin replacement therapy. This clinical program is set out to support immunoglobulin replacement therapy through home, self-administered subcutaneous immunoglobulin (SCIG) infusion. That Support is provided through hospital-based outpatient clinics with nursing coordination. The main objectives of the program are to provide consistent, standardized diagnosis and management of immunodeficiencies requiring immunoglobulin treatment.
Dr. Cowan has served as co-lead of the special immunization clinic network of the Canadian Immunization Research Network since 2023. Her dedication and contribution to immunization in immunocompromised patients is recognized locally and nationally.
Research Goals and Interests
News
Publications
Dengue among immunocompromised patients: a systematic review and meta-analysis
2025-09-06 Go to publicationImmunoglobulin treatment and clinical outcomes: data from the Ontario Immunoglobulin Treatment program multicenter case registry
2025-07-01 Go to publicationHumoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections
2025-01-21 Go to publicationNeurological adverse events following COVID-19 vaccination among Canadians referred to the special immunization clinic network
2025-01-01Patient-reported outcomes with subcutaneous immunoglobulin in secondary immunodeficiency
2025-01-01